RemedyMD to Launch New Leukemia and Lymphoma Registries at 2011 ASH Annual Meeting
Next-Generation Hematology Registries Enable Researchers to Harmonize Data From Diverse Sources and Recognize Undiscovered Patterns
(firmenpresse) - SALT LAKE CITY, UT -- (Marketwire) -- 12/06/11 -- RemedyMD, the leading provider of registries for Life Science Research, will launch the Mosaic Lymphoma™ and Mosaic Leukemia™ registries at the American Society of Hematology annual meeting and exposition December 10-13 in San Diego, Calif. (Booth #819).
"Our Mosaic Lymphoma and Mosaic Leukemia registries were designed with the needs of researcher and clinician in mind," said Jonathan Dewey, MD, Clinical Director for RemedyMD. "These registries include all of the key data elements researchers need to study these diseases and the content required by the Commission on Cancer for reporting to the FORDS database."
Built on the powerful Mosaic™ Platform, these new registries also offer researchers powerful tools for customizing the registry and adapting to changing research needs over time. Researchers benefit from:
Integrate and harmonize data from disparate sources as the Mosaic ontology ensures semantic consistency and integrity of the data.
Get all the benefits of a structured data model (pre-defined data elements, valid values and mapping of relationships between terms), and also add data elements and map new concepts, as research needs change over time.
Make changes to existing electronic data capture forms and develop completely new forms -- without IT department assistance.
Use cutting-edge data visualization tools to develop interactive charts, graphs and dashboards and recognize patterns from the largest data set to the smallest cohort and easily configurable reporting tools with "drag and drop" functionality to develop your own queries when and as you need -- with no waiting on IT department assistance.
Report data to national registries and cooperative groups like FORDS more easily.
In addition to Mosaic Leukemia and Mosaic Lymphoma, RemedyMD also offers ComprehensiveBMT™, a registry solution designed to revolutionize hematopoietic stem cell transplant center reporting and analytics. These registries are the latest offerings in a growing line of research management systems specifically designed to meet the challenges faced by life science researchers.
"Research is fundamentally an exercise in pattern recognition," said Gary Kennedy, Founder and CEO of RemedyMD. "The new Mosaic Lymphoma and Mosaic Leukemia registries provide researchers with the technology tools they need to gain a subject-centered, 360-degree view of their data in order to recognize new patterns and increase the speed of discovery."
RemedyMD will have representatives on site throughout the to answer questions, offer demonstrations and introduce the Leukemia and Lymphoma registries.
To request a demo of RemedyMD's new off-the-shelf Leukemia and Lymphoma registries, please contact us at . To learn more about RemedyMD's next-generation Life Science Research applications, please visit our website, .
RemedyMD is the leading provider of registries and registry-based applications for life science research. RemedyMD's is cutting-edge which enables researchers, clinicians and scientists to collect, aggregate, harmonize, and analyze data from widely disparate sources and then use Mosaic™ Platform tools and applications to identify patterns that result in accelerated discoveries and better . For more information visit: .
Kristofer Beldin
RemedyMD
(801) 870-9407 (cell)
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 06.12.2011 - 10:30 Uhr
Sprache: Deutsch
News-ID 94230
Anzahl Zeichen: 0
contact information:
Town:
SALT LAKE CITY, UT
Kategorie:
Healthcare
Diese Pressemitteilung wurde bisher 308 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"RemedyMD to Launch New Leukemia and Lymphoma Registries at 2011 ASH Annual Meeting"
steht unter der journalistisch-redaktionellen Verantwortung von
RemedyMD (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
